investing-statsSEC Form 4 insider transactions

CORT · CORCEPT THERAPEUTICS INC

← all insiders

Pharmaceutical Preparations · Listed on Nasdaq

Open-market insider flow over 30d · 90d · 180d · 365d · filter in table · CSV · JSON

Open-market trades61
Distinct insiders9
Bought$0
Sold$59.73M
Net flow$-59.73M

Recent filings

How to read this

Filed
Date the Form 4 was filed with the SEC. Insiders must file within 2 business days of the trade.
Ticker
The issuer's stock symbol. Select it to open that company's insider-activity page.
Issuer
The company whose shares were traded.
Sector
The issuer's industry (SEC SIC classification). Select a value to filter to that sector.
Insider
The reporting person: an officer, director, or 10% owner. Select a name to see all of their trades.
Role
The insider's relationship to the company: director, officer, or 10% owner.
Code
SEC transaction code describing the kind of transaction. Full official definitions are under “Transaction codes” below. A dot marks an open-market trade (P/S), the highest-conviction signal.
Side
Direction of the trade, from the filing's Acquired (A) ▲ / Disposed of (D) ▼ field: a buy or a sell.
10b5-1
Trade made under a pre-arranged Rule 10b5-1 plan: scheduled in advance, not a discretionary decision (generally lower signal).
Shares
Number of shares in this transaction.
Price
Reported price per share. Blank for grants, gifts, and other trades with no stated price.
Value
Transaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ for their impact).
Owned after
Form 4 column “Amount of Securities Beneficially Owned Following Reported Transaction(s)”: shares the insider held (directly or indirectly) immediately after this trade.
Own Δ
How much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing.
Co. Δ
Change in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake. Based on the latest reported shares outstanding; blank when unavailable.
D/I
Form 4 column “Ownership Form: Direct (D) or Indirect (I)”. Indirect holdings (for example, through a trust, fund, or family member) are detailed in the filing's “Nature of Indirect Beneficial Ownership.”
Lag
Days from the trade date to the filing date (Form 4 is due within 2 business days).

Transaction codes

Verbatim from the SEC's General Instructions for Forms 3, 4 and 5.

P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award or other acquisition pursuant to Rule 16b-3(d)
D
Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
F
Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
M
Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
G
Bona fide gift
C
Conversion of derivative security
X
Exercise of in-the-money or at-the-money derivative security
J
Other acquisition or disposition (describe transaction)
Recent Form 4 filings for CORT
FiledDate the Form 4 was filed with the SEC (due within 2 business days of the trade).InsiderRoleCodeSEC transaction code describing the kind of transaction. See “How to read this” above for the official SEC definition of each code. The dot marks an open-market trade (P/S).SideDirection of the trade: a buy (acquired ▲) or a sell (disposed ▼).SharesNumber of shares in this transaction.PriceReported price per share. Blank for trades with no stated price.ValueTransaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ).Owned afterShares the insider held (directly or indirectly) immediately after this trade.Own ΔHow much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing.Co. ΔChange in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake in the company. Based on the latest reported shares outstanding; blank when unavailable.Link to SEC filing
2026-08-20MAHONEY DAVID LDirectorS sell10b5-191,1670$118.24$10.78M1,140,994−7%−0.08% (now 1.1%)filing
2026-05-29Maduck SeanOfficer (See Remarks)S sell10b5-154,5750$65.37$3.57M29,402−65%−0.05% (now 0.03%)filing
2026-08-28Park KimberlyDirectorS sell26,6850$122.55$3.27M0−100%−0.02% (now 0%)filing
2026-08-27Maduck SeanOfficer (See Remarks)S sell10b5-125,0850$125.47$3.15M15,625−62%−0.02% (now 0.01%)filing
2026-06-03Mokari AtabakOfficer (Chief Financial Officer)S sell10b5-140,0000$70.00$2.80M15,257−72%−0.04% (now 0.01%)filing
2026-09-03Vieira Roberto WandenkolkOfficer (President, Oncology)S sell10b5-123,7700$110.70$2.63M15,205−61%−0.02% (now 0.01%)filing
2026-09-03Vieira Roberto WandenkolkOfficer (President, Oncology)S sell10b5-123,6000$109.35$2.58M38,975−38%−0.02% (now 0.04%)filing
2026-07-17Mokari AtabakOfficer (Chief Financial Officer)S sell10b5-128,4600$87.89$2.50M19,751−59%−0.03% (now 0.02%)filing
2026-08-05Maduck SeanOfficer (See Remarks)S sell10b5-120,3050$114.70$2.33M9,755−68%−0.02% (now <0.01%)filing
2026-05-05BELANOFF JOSEPH KDirector, Officer (Chief Executive Officer)S sell10b5-140,0000$50.10$2.00M2,878,326−1%−0.04% (now 2.7%)filing
2026-08-03Mokari AtabakOfficer (Chief Financial Officer)M buy10b5-180,0000$23.06$1.84M96,1306.0×+0.07% (now 0.09%)filing
2026-08-03Mokari AtabakOfficer (Chief Financial Officer)S sell10b5-115,4770$114.96$1.78M59,595−21%−0.01% (now 0.06%)filing
2026-07-08Guyer WilliamOfficer (Chief Development Officer)S sell10b5-119,0480$93.11$1.77M4,937−79%−0.02% (now <0.01%)filing
2026-06-18MAHONEY DAVID LDirectorS sell20,0000$84.53$1.69M26,147−43%−0.02% (now 0.02%)filing
2026-08-03Mokari AtabakOfficer (Chief Financial Officer)S sell10b5-114,2220$115.87$1.65M45,373−24%−0.01% (now 0.04%)filing
2026-06-17Mokari AtabakOfficer (Chief Financial Officer)S sell10b5-119,4830$81.81$1.59M16,132−55%−0.02% (now 0.01%)filing
2026-06-03Maduck SeanOfficer (See Remarks)S sell10b5-121,0690$70.11$1.48M12,908−62%−0.02% (now 0.01%)filing
2026-06-04Guyer WilliamOfficer (Chief Development Officer)S sell10b5-120,0000$70.60$1.41M3,985−83%−0.02% (now <0.01%)filing
2026-05-29Maduck SeanOfficer (See Remarks)S sell10b5-120,4250$66.16$1.35M8,977−69%−0.02% (now <0.01%)filing
2026-09-03Maduck SeanOfficer (See Remarks)S sell10b5-111,7300$113.94$1.34M23,025−34%−0.01% (now 0.02%)filing
2026-03-27BELANOFF JOSEPH KDirector, Officer (Chief Executive Officer)S sell10b5-126,1980$50.07$1.31M2,918,326−0.9%−0.02% (now 2.7%)filing
2026-08-12Guyer WilliamOfficer (Chief Development Officer)S sell10b5-111,5300$113.18$1.30M8,755−57%−0.01% (now <0.01%)filing
2026-09-03Vieira Roberto WandenkolkOfficer (President, Oncology)M buy10b5-158,3330$21.63$1.26M62,57515×+0.05% (now 0.06%)filing
2026-09-03Maduck SeanOfficer (See Remarks)S sell10b5-110,9890$114.71$1.26M12,036−48%−0.01% (now 0.01%)filing
2026-08-18Robb Gary CharlesOfficer (Chief Business Officer)S sell10,0000$116.26$1.16M39,716−20%−<0.01% (now 0.04%)filing
2026-05-07Guyer WilliamOfficer (Chief Development Officer)S sell10b5-120,0000$51.83$1.04M2,231−90%−0.02% (now <0.01%)filing
2026-07-06Maduck SeanOfficer (See Remarks)S sell10b5-111,1750$89.31$998.0K9,755−53%−0.01% (now <0.01%)filing
2026-08-03Mokari AtabakOfficer (Chief Financial Officer)S sell10b5-18,2670$117.93$975.0K30,017−22%−<0.01% (now 0.03%)filing
2026-08-03Mokari AtabakOfficer (Chief Financial Officer)S sell10b5-18,1030$119.95$971.9K17,131−32%−<0.01% (now 0.02%)filing
2026-07-06Maduck SeanOfficer (See Remarks)S sell10b5-111,0240$87.33$962.8K23,731−32%−0.01% (now 0.02%)filing
2026-08-03Mokari AtabakOfficer (Chief Financial Officer)S sell10b5-18,9560$106.96$957.9K82,974−10%−<0.01% (now 0.08%)filing
2026-06-17Mokari AtabakOfficer (Chief Financial Officer)S sell10b5-111,0810$80.94$896.9K35,615−24%−0.01% (now 0.03%)filing
2026-06-02BELANOFF JOSEPH KDirector, Officer (Chief Executive Officer)S sell10b5-112,8370$69.74$895.3K2,565,489−0.5%−0.01% (now 2.4%)filing
2026-08-20MAHONEY DAVID LDirectorS sell10b5-17,0550$118.88$838.7K1,133,939−0.6%−<0.01% (now 1.0%)filing
2026-08-03Mokari AtabakOfficer (Chief Financial Officer)S sell10b5-17,0890$116.96$829.1K38,284−16%−<0.01% (now 0.04%)filing
2026-04-08Guyer WilliamOfficer (Chief Development Officer)S sell10b5-120,0000$40.97$819.4K2,231−90%−0.02% (now <0.01%)filing
2026-06-17Mokari AtabakOfficer (Chief Financial Officer)M buy10b5-140,0000$19.26$770.4K56,1303.5×+0.04% (now 0.05%)filing
2026-06-03Mokari AtabakOfficer (Chief Financial Officer)M buy10b5-140,0000$19.26$770.4K55,2573.6×+0.04% (now 0.05%)filing
2026-06-17Mokari AtabakOfficer (Chief Financial Officer)S sell10b5-19,4340$80.02$754.9K46,696−17%−<0.01% (now 0.04%)filing
2026-08-27Maduck SeanOfficer (See Remarks)S sell10b5-15,8700$126.06$740.0K9,755−38%−<0.01% (now <0.01%)filing
2026-07-17Mokari AtabakOfficer (Chief Financial Officer)S sell10b5-17,9190$86.78$687.2K48,211−14%−<0.01% (now 0.04%)filing
2026-09-03Vieira Roberto WandenkolkOfficer (President, Oncology)S sell10b5-15,6210$114.58$644.0K5,467−51%−<0.01% (now <0.01%)filing
2026-05-29Maduck SeanOfficer (See Remarks)M buy10b5-175,0000$8.27$620.3K83,9779.4×+0.07% (now 0.08%)filing
2026-08-20MAHONEY DAVID LDirectorS sell10b5-14,9840$117.47$585.5K1,232,161−0.4%−<0.01% (now 1.1%)filing
2026-08-03Mokari AtabakOfficer (Chief Financial Officer)S sell10b5-14,7830$118.73$567.9K25,234−16%−<0.01% (now 0.02%)filing
2026-07-17Mokari AtabakOfficer (Chief Financial Officer)M buy10b5-124,1670$23.06$557.3K56,130+76%+0.02% (now 0.05%)filing
2026-08-12Guyer WilliamOfficer (Chief Development Officer)S sell10b5-14,7700$114.04$544.0K3,985−54%−<0.01% (now <0.01%)filing
2026-08-03Mokari AtabakOfficer (Chief Financial Officer)S sell10b5-14,7000$113.18$531.9K75,072−6%−<0.01% (now 0.07%)filing
2026-08-18WILSON JAMES NDirectorS sell10b5-14,6680$111.44$520.2K1,076,822−0.4%−<0.01% (now 1.00%)filing
2026-06-18WILSON JAMES NDirectorS sell10b5-15,8230$83.57$486.6K1,094,543−0.5%−<0.01% (now 1.0%)filing
2026-08-03Mokari AtabakOfficer (Chief Financial Officer)S sell10b5-14,2000$105.54$443.2K91,930−4%−<0.01% (now 0.09%)filing
2026-07-08Guyer WilliamOfficer (Chief Development Officer)M buy10b5-120,0000$21.65$433.0K23,9856.0×+0.02% (now 0.02%)filing
2026-06-04Guyer WilliamOfficer (Chief Development Officer)M buy10b5-120,0000$21.65$433.0K23,9856.0×+0.02% (now 0.02%)filing
2026-05-07Guyer WilliamOfficer (Chief Development Officer)M buy10b5-120,0000$21.65$433.0K22,23110.0×+0.02% (now 0.02%)filing
2026-04-08Guyer WilliamOfficer (Chief Development Officer)M buy10b5-120,0000$21.65$433.0K22,23110.0×+0.02% (now 0.02%)filing
2026-03-24Guyer WilliamOfficer (Chief Development Officer)S sell10b5-111,7670$36.01$423.7K2,231−84%−0.01% (now <0.01%)filing
2026-08-18Maduck SeanOfficer (See Remarks)S sell10b5-13,6640$114.49$419.5K9,755−27%−<0.01% (now <0.01%)filing
2026-08-06Guyer WilliamOfficer (Chief Development Officer)S sell10b5-13,7000$113.12$418.6K3,985−48%−<0.01% (now <0.01%)filing
2026-08-28Park KimberlyDirectorF sell3,3150$122.09$404.7K26,685−11%−<0.01% (now 0.02%)filing
2026-08-28Park KimberlyDirectorM buy30,0000$13.49$404.7K30,000new+0.03% (now 0.03%)filing
2026-08-12Guyer WilliamOfficer (Chief Development Officer)M buy10b5-116,3000$21.65$352.9K20,2855.1×+0.02% (now 0.02%)filing
2026-08-27Maduck SeanOfficer (See Remarks)M buy10b5-130,9550$11.35$351.3K40,7104.2×+0.03% (now 0.04%)filing
2026-07-17WILSON JAMES NDirectorS sell10b5-13,9690$87.74$348.2K1,089,495−0.4%−<0.01% (now 1.0%)filing
2026-06-18WILSON JAMES NDirectorS sell10b5-14,1770$82.69$345.4K1,100,366−0.4%−<0.01% (now 1.0%)filing
2026-08-18WILSON JAMES NDirectorS sell10b5-13,0530$110.49$337.3K1,081,490−0.3%−<0.01% (now 1.0%)filing
2026-05-29Lyon Joseph DouglasOfficer (See Remarks)S sell5,0000$65.00$325.0K6,230−45%−<0.01% (now <0.01%)filing
2026-07-17Mokari AtabakOfficer (Chief Financial Officer)S sell10b5-13,5200$88.30$310.8K16,231−18%−<0.01% (now 0.02%)filing
2026-07-17Mokari AtabakOfficer (Chief Financial Officer)M buy10b5-115,8330$19.26$304.9K31,963+98%+0.01% (now 0.03%)filing
2026-06-03Maduck SeanOfficer (See Remarks)S sell10b5-13,9310$70.75$278.1K8,977−30%−<0.01% (now <0.01%)filing
2026-07-17WILSON JAMES NDirectorS sell10b5-12,9740$88.81$264.1K1,086,521−0.3%−<0.01% (now 1.0%)filing
2026-09-03Maduck SeanOfficer (See Remarks)S sell10b5-12,2810$115.61$263.7K9,755−19%−<0.01% (now <0.01%)filing
2026-08-18WILSON JAMES NDirectorS sell10b5-12,2790$112.64$256.7K1,074,543−0.2%−<0.01% (now 0.99%)filing
2026-03-24Guyer WilliamOfficer (Chief Development Officer)M buy10b5-111,7670$21.65$254.8K13,9986.3×+0.01% (now 0.01%)filing
2026-07-06Maduck SeanOfficer (See Remarks)S sell10b5-12,8010$88.51$247.9K20,930−12%−<0.01% (now 0.02%)filing
2026-08-03Mokari AtabakOfficer (Chief Financial Officer)S sell10b5-12,2020$110.03$242.3K80,372−3%−<0.01% (now 0.07%)filing
2026-09-03Maduck SeanOfficer (See Remarks)M buy10b5-125,0000$8.27$206.8K34,7553.6×+0.02% (now 0.03%)filing
2026-07-06Maduck SeanOfficer (See Remarks)M buy10b5-125,0000$8.27$206.8K34,7553.6×+0.02% (now 0.03%)filing
2026-06-03Maduck SeanOfficer (See Remarks)M buy10b5-125,0000$8.27$206.8K33,9773.8×+0.02% (now 0.03%)filing
2026-09-03Vieira Roberto WandenkolkOfficer (President, Oncology)S sell10b5-11,6060$113.72$182.6K11,088−13%−<0.01% (now 0.01%)filing
2026-07-17WILSON JAMES NDirectorS sell10b5-11,9780$89.49$177.0K1,084,543−0.2%−<0.01% (now 1.0%)filing
2026-08-05Lyon Joseph DouglasOfficer (See Remarks)S sell1,5400$114.16$175.8K5,495−22%−<0.01% (now <0.01%)filing
2026-09-03Vieira Roberto WandenkolkOfficer (President, Oncology)S sell10b5-11,5370$111.37$171.2K13,668−10%−<0.01% (now 0.01%)filing
2026-08-05Maduck SeanOfficer (See Remarks)M buy10b5-120,3050$8.27$167.9K30,0603.1×+0.02% (now 0.03%)filing
2026-09-03Vieira Roberto WandenkolkOfficer (President, Oncology)S sell10b5-11,2250$115.44$141.4K4,242−22%−<0.01% (now <0.01%)filing
2026-08-03Mokari AtabakOfficer (Chief Financial Officer)S sell10b5-11,0010$120.67$120.8K16,130−6%−<0.01% (now 0.01%)filing
2026-08-12Maduck SeanOfficer (See Remarks)S sell10b5-11,0310$114.52$118.1K9,755−10%−<0.01% (now <0.01%)filing
2026-09-03Vieira Roberto WandenkolkOfficer (President, Oncology)S sell10b5-19740$112.40$109.5K12,694−7%−<0.01% (now 0.01%)filing
2026-07-17WILSON JAMES NDirectorS sell10b5-11,0790$86.78$93.6K1,093,464−<0.1%−<0.01% (now 1.0%)filing
2026-07-08Guyer WilliamOfficer (Chief Development Officer)S sell10b5-19520$93.54$89.0K3,985−19%−<0.01% (now <0.01%)filing
2026-08-06Guyer WilliamOfficer (Chief Development Officer)M buy10b5-13,7000$21.65$80.1K7,685+93%+<0.01% (now <0.01%)filing
2026-08-03Mokari AtabakOfficer (Chief Financial Officer)S sell10b5-16000$110.95$66.6K79,772−0.7%−<0.01% (now 0.07%)filing
2026-06-03Guyer WilliamOfficer (Chief Development Officer)A buy8770$70.44$61.8K3,108+39%+<0.01% (now <0.01%)filing
2026-06-03Robb Gary CharlesOfficer (Chief Business Officer)A buy7760$70.44$54.7K25,263+3%+<0.01% (now 0.02%)filing
2026-08-20MAHONEY DAVID LDirectorS sell10b5-14000$119.64$47.9K1,133,539−<0.1%−<0.01% (now 1.0%)filing
2026-06-03Mokari AtabakOfficer (Chief Financial Officer)A buy10b5-16340$70.44$44.7K15,891+4%+<0.01% (now 0.01%)filing
2026-08-03Mokari AtabakOfficer (Chief Financial Officer)S sell10b5-14000$108.46$43.4K82,574−0.5%−<0.01% (now 0.08%)filing
2026-06-03Maduck SeanOfficer (See Remarks)A buy10b5-16150$70.44$43.3K9,592+7%+<0.01% (now <0.01%)filing
2026-06-03Lyon Joseph DouglasOfficer (See Remarks)A buy5370$70.44$37.8K6,767+9%+<0.01% (now <0.01%)filing
2026-06-03Maduck SeanOfficer (See Remarks)F sell10b5-14520$70.44$31.8K9,755−4%−<0.01% (now <0.01%)filing
2026-08-18Maduck SeanOfficer (See Remarks)M buy10b5-13,6640$8.27$30.3K13,419+38%+<0.01% (now 0.01%)filing
2026-06-03Mokari AtabakOfficer (Chief Financial Officer)F sell10b5-13950$70.44$27.8K16,130−2%−<0.01% (now 0.01%)filing
2026-06-03Robb Gary CharlesOfficer (Chief Business Officer)F sell3580$70.44$25.2K25,681−1%−<0.01% (now 0.02%)filing
2026-06-03Lyon Joseph DouglasOfficer (See Remarks)F sell2690$70.44$18.9K7,035−4%−<0.01% (now <0.01%)filing
2026-09-03Guyer WilliamOfficer (Chief Development Officer)A buy1640$113.38$18.6K4,149+4%+<0.01% (now <0.01%)filing
2026-09-03Robb Gary CharlesOfficer (Chief Business Officer)A buy1640$113.38$18.6K13,590+1%+<0.01% (now 0.01%)filing
2026-09-03Maduck SeanOfficer (See Remarks)A buy10b5-11500$113.38$17.0K9,905+2%+<0.01% (now <0.01%)filing
2026-09-03Mokari AtabakOfficer (Chief Financial Officer)A buy1380$113.38$15.6K16,268+0.9%+<0.01% (now 0.02%)filing
2026-09-03Vieira Roberto WandenkolkOfficer (President, Oncology)A buy10b5-11380$113.38$15.6K4,206+3%+<0.01% (now <0.01%)filing
2026-09-03Lyon Joseph DouglasOfficer (See Remarks)A buy1300$113.38$14.7K5,625+2%+<0.01% (now <0.01%)filing
2026-09-03Maduck SeanOfficer (See Remarks)F sell10b5-11170$113.38$13.3K9,938−1%−<0.01% (now <0.01%)filing
2026-09-03Mokari AtabakOfficer (Chief Financial Officer)F sell1020$113.38$11.6K16,304−0.6%−<0.01% (now 0.02%)filing
2026-09-03Vieira Roberto WandenkolkOfficer (President, Oncology)F sell10b5-11020$113.38$11.6K4,242−2%−<0.01% (now <0.01%)filing
2026-09-03Robb Gary CharlesOfficer (Chief Business Officer)F sell910$113.38$10.3K13,663−0.7%−<0.01% (now 0.01%)filing
2026-07-17Mokari AtabakOfficer (Chief Financial Officer)S sell10b5-11010$89.43$9.0K16,130−0.6%−<0.01% (now 0.01%)filing
2026-08-12Maduck SeanOfficer (See Remarks)M buy10b5-11,0310$8.27$8.5K10,786+11%+<0.01% (now <0.01%)filing
2026-09-03Lyon Joseph DouglasOfficer (See Remarks)F sell720$113.38$8.2K5,683−1%−<0.01% (now <0.01%)filing
2026-06-17Mokari AtabakOfficer (Chief Financial Officer)S sell10b5-120$82.45$16516,130−<0.1%−<0.01% (now 0.01%)filing
2026-09-03Guyer WilliamOfficer (Chief Development Officer)A buy16404,313+4%+<0.01% (now <0.01%)filing
2026-09-03Maduck SeanOfficer (See Remarks)A buy10b5-1150010,055+2%+<0.01% (now <0.01%)filing
2026-09-03Maduck SeanOfficer (See Remarks)M sell10b5-125,000 25,000 Common Stock66,986filing
2026-09-03Mokari AtabakOfficer (Chief Financial Officer)A buy138016,406+0.8%+<0.01% (now 0.02%)filing
2026-09-03Robb Gary CharlesOfficer (Chief Business Officer)A buy164013,754+1%+<0.01% (now 0.01%)filing
2026-09-03Vieira Roberto WandenkolkOfficer (President, Oncology)A buy10b5-113804,344+3%+<0.01% (now <0.01%)filing
2026-09-03Vieira Roberto WandenkolkOfficer (President, Oncology)M sell10b5-158,333 58,333 Common Stock141,667filing
2026-09-03Lyon Joseph DouglasOfficer (See Remarks)A buy13005,755+2%+<0.01% (now <0.01%)filing
2026-08-28Park KimberlyDirectorM sell30,000 30,000 Common Stock30,000filing
2026-08-27Maduck SeanOfficer (See Remarks)M sell10b5-130,955 30,955 Common Stock169,045filing
2026-08-18Maduck SeanOfficer (See Remarks)M sell10b5-13,664 3,664 Common Stock91,986filing
2026-08-18Robb Gary CharlesOfficer (Chief Business Officer)G sell125013,426−0.9%−<0.01% (now 0.01%)filing
2026-08-14Robb Gary CharlesOfficer (Chief Business Officer)G sell11,530013,551−46%−0.01% (now 0.01%)filing
2026-08-14Robb Gary CharlesOfficer (Chief Business Officer)G buy3,000015,571+24%+<0.01% (now 0.01%)filing
2026-08-14Robb Gary CharlesOfficer (Chief Business Officer)G buy3,000015,571+24%+<0.01% (now 0.01%)filing
2026-08-12Maduck SeanOfficer (See Remarks)M sell10b5-11,031 1,031 Common Stock95,650filing
2026-08-12Guyer WilliamOfficer (Chief Development Officer)M sell10b5-116,300 16,300 Common Stock110,000filing
2026-08-06Guyer WilliamOfficer (Chief Development Officer)M sell10b5-13,700 3,700 Common Stock126,300filing
2026-08-05Maduck SeanOfficer (See Remarks)M sell10b5-120,305 20,305 Common Stock96,681filing
2026-08-03Mokari AtabakOfficer (Chief Financial Officer)M sell10b5-180,000 80,000 Common Stock95,833filing
2026-07-17Mokari AtabakOfficer (Chief Financial Officer)M sell10b5-115,833 15,833 Common Stock4,167filing
2026-07-17Mokari AtabakOfficer (Chief Financial Officer)M sell10b5-124,167 24,167 Common Stock175,833filing
2026-07-08Robb Gary CharlesOfficer (Chief Business Officer)G sell600025,081−2%−<0.01% (now 0.02%)filing
2026-07-08Guyer WilliamOfficer (Chief Development Officer)M sell10b5-120,000 20,000 Common Stock130,000filing
2026-07-06Maduck SeanOfficer (See Remarks)M sell10b5-125,000 25,000 Common Stock116,986filing
2026-06-17Mokari AtabakOfficer (Chief Financial Officer)M sell10b5-140,000 40,000 Common Stock20,000filing
2026-06-04Guyer WilliamOfficer (Chief Development Officer)M sell10b5-120,000 20,000 Common Stock150,000filing
2026-06-03Robb Gary CharlesOfficer (Chief Business Officer)A buy776026,039+3%+<0.01% (now 0.02%)filing
2026-06-03Mokari AtabakOfficer (Chief Financial Officer)A buy10b5-1634016,525+4%+<0.01% (now 0.02%)filing
2026-06-03Mokari AtabakOfficer (Chief Financial Officer)M sell10b5-140,000 40,000 Common Stock60,000filing
2026-06-03Maduck SeanOfficer (See Remarks)A buy10b5-1615010,207+6%+<0.01% (now <0.01%)filing
2026-06-03Maduck SeanOfficer (See Remarks)M sell10b5-125,000 25,000 Common Stock141,986filing
2026-06-03Guyer WilliamOfficer (Chief Development Officer)A buy87703,985+28%+<0.01% (now <0.01%)filing
2026-06-03Lyon Joseph DouglasOfficer (See Remarks)A buy53707,304+8%+<0.01% (now <0.01%)filing
2026-06-02BELANOFF JOSEPH KDirector, Officer (Chief Executive Officer)G sell10b5-1300,00002,578,326−10%−0.28% (now 2.4%)filing
2026-06-02BELANOFF JOSEPH KDirector, Officer (Chief Executive Officer)G buy10b5-1150,0000150,000new+0.14% (now 0.14%)filing
2026-06-02BELANOFF JOSEPH KDirector, Officer (Chief Executive Officer)G buy10b5-1150,0000150,000new+0.14% (now 0.14%)filing
2026-05-29WILSON JAMES NDirectorG sell892,05609,011−99%−0.83% (now <0.01%)filing
2026-05-29WILSON JAMES NDirectorG sell9,01100−100%−<0.01% (now 0%)filing
2026-05-29WILSON JAMES NDirectorG buy9,01101,104,543+0.8%+<0.01% (now 1.0%)filing
2026-05-29Maduck SeanOfficer (See Remarks)M sell10b5-175,000 75,000 Common Stock166,986filing
2026-05-26Alton Gregg HDirectorA buy12,500 12,500 Common Stock12,500filing
2026-05-26BAKER G LEONARD JRDirectorA buy12,500 12,500 Common Stock12,500filing
2026-05-26Park KimberlyDirectorA buy12,500 12,500 Common Stock12,500filing
2026-05-26MAHONEY DAVID LDirectorA buy12,500 12,500 Common Stock12,500filing
2026-05-26Murray Joshua M.DirectorA buy12,500 12,500 Common Stock12,500filing
2026-05-26Swisher Daniel N JRDirectorA buy12,500 12,500 Common Stock12,500filing
2026-05-26WILSON JAMES NDirectorA buy12,500 12,500 Common Stock12,500filing
2026-05-15Robb Gary CharlesOfficer (Chief Business Officer)G sell5,300024,487−18%−<0.01% (now 0.02%)filing
2026-05-15Robb Gary CharlesOfficer (Chief Business Officer)G buy1,000012,571+9%+<0.01% (now 0.01%)filing
2026-05-15Robb Gary CharlesOfficer (Chief Business Officer)G buy1,000012,571+9%+<0.01% (now 0.01%)filing
2026-05-07Guyer WilliamOfficer (Chief Development Officer)M sell10b5-120,000 20,000 Common Stock170,000filing
2026-04-24WILSON JAMES NDirectorG sell2,00001,095,532−0.2%−<0.01% (now 1.0%)filing
2026-04-08WILSON JAMES NDirectorG sell5,00001,097,532−0.5%−<0.01% (now 1.0%)filing
2026-04-08Guyer WilliamOfficer (Chief Development Officer)M sell10b5-120,000 20,000 Common Stock190,000filing
2026-03-24Guyer WilliamOfficer (Chief Development Officer)M sell10b5-111,767 11,767 Common Stock210,000filing
2026-03-24WILSON JAMES NDirectorG sell4,00001,102,532−0.4%−<0.01% (now 1.0%)filing

Up to 200 most recent filings · select a heading to sort, or open “How to read this” above for definitions · this company on SEC EDGAR.